Dr. Debashish Bose is a leading expert in complex oncology and GI surgeries, offering minimally invasive and robotic options for a range of cancers including pancreatic and liver disease.
Inflammatory bowel disease, or IBD, includes disorders that cause inflammation of the intestines. IBD is treated at Mercy by expert gastroenterologists.
Dr. David Riseberg, Chief of Medical Oncology and Hematology at Mercy, leads a team of Board Certified physicians who provide compassionate care and comprehensive treatment plans.
Mercy offers emergency care on the Downtown Baltimore campus 24 hours a day, 7 days a week (410-332-9477) with access to a trained emergency medicine team, diagnostic services and consultations with specialists.
In case of an Emergency, Dial 911 and follow the instructions of the EMS (Emergency Medical Services) team.
Mercy Medical Center's downtown campus includes our Main Hospital - The Mary Catherine Bunting Center, McAuley Plaza and The Weinberg Center.
General visiting hours at Mercy are 11:00 am to 8:30 pm. Hours vary by floor, please check with the nursing staff or call 410-332-9555.
Chemoembolization is one of the many innovative treatments options offered at Mercy Medical Center in Baltimore, Maryland. Mercy’s medical oncologists are experts dedicated to providing patients with the best treatment options for cancer.
Chemoembolization is a minimally invasive, image-guided treatment that delivers a high dose of chemotherapy directly into the tumor, while minimizing exposure to healthy tissues. This technique is mainly used to treat liver cancer and can be used for treatment of cancers that have metastasized to the liver. Chemoembolization typically requires a short hospital stay.
An interventional radiologist performs chemoemobilzation by inserting a small catheter into the groin and the blood vessels supplying blood to the liver tumor. Chemotherapy drugs are then delivered directly to the tumor allowing other areas of the liver and other parts of the body to be spared from the chemotherapy drugs. This technique has been shown to slow or stop tumor growth, and in some cases can even result in significant shrinkage of the tumor.
Before a patient can be considered for chemoembolization, a medical evaluation is performed. The evaluation will include several tests to make sure there are no blockages of the portal vein or bile ducts:
Chemoembolization is not a curative treatment. It is only effective for treating primary liver tumors also known as hepatocellular carcinoma or hepatoma. It can also be used to treat cancers that have spread or metastasized to the liver such as colon cancer, carcinoid, ocular melanoma and sarcomas.
A 2020 TOP DOC Dr. Sandy Kotiah serves as the Director of The Neuroendocrine Tumor Center at Mercy and leads a multidisciplinary team of doctors focused on providing some of the best treatment options for rare neuroendocrine diseases.
A team of Mercy doctors and an indomitable spirit keep a Baltimore woman going through a series of health issues.